Cat. No.: X25-04-YM999
DOTA agent, Alginate-PEG-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid, Purity ≥95%
Synonym: 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-PEG-alginate
Size
100 mg; 250 mg; 500 mg; 1 g; 5 g
| Sub Cat. No. |
Molecular Weight |
Glycan Name |
Functional Group |
Inquiry |
| X25-04-YM999-1 |
PEG 350 Da |
Alginate |
DOTA |
Inquiry
|
| X25-04-YM999-2 |
PEG 550 Da |
Alginate |
DOTA |
Inquiry
|
| X25-04-YM999-3 |
PEG 750 Da |
Alginate |
DOTA |
Inquiry
|
| X25-04-YM999-4 |
PEG 1 kDa |
Alginate |
DOTA |
Inquiry
|
| X25-04-YM999-5 |
PEG 2 kDa |
Alginate |
DOTA |
Inquiry
|
| X25-04-YM999-6 |
PEG 3 kDa |
Alginate |
DOTA |
Inquiry
|
| X25-04-YM999-7 |
PEG 4 kDa |
Alginate |
DOTA |
Inquiry
|
| X25-04-YM999-8 |
PEG 5 kDa |
Alginate |
DOTA |
Inquiry
|
| X25-04-YM999-9 |
PEG 10 kDa |
Alginate |
DOTA |
Inquiry
|
| X25-04-YM999-10 |
PEG 20 kDa |
Alginate |
DOTA |
Inquiry
|
Properties
Description
Alginate-PEG-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid, or DOTA-PEG-alginate, is a conjugate for research purposes, attaching alginate (a biocompatible, gel-forming polysaccharide) to DOTA via PEG. Adjustable PEG (350, 550, 750, 1k, 2k, 3k, 4k, 5k, 10k, or 20k Da) enhances dissolution, prolongs circulation, and regulates release kinetics.
Source
Chemical synthesis
Impurities
No visible impurities to the naked eye.
Solubility
This product is soluble in most organic solvents, such as DCM, DMF, DMSO, and THF, and exhibits excellent solubility in water.
Identity
Confirmed by NMR.
Stability
It is stable under its storage temperature.
Quality Level
Research level
Applications
Alginate-PEG-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid plays a key role in enabling artificial extracellular matrix remodeling through enzyme-responsive networks.
Storage
Store at -20°C, protect from light and moisture.
For Research Use Only. Not For Clinical Use.